Literature DB >> 26503544

Measures of body adiposity and visceral adiposity index as predictors of metabolic syndrome among Thai women with PCOS.

Kitirat Techatraisak1, Krissanee Wongmeerit1, Chongdee Dangrat1, Thanyarat Wongwananuruk1, Suchada Indhavivadhana1.   

Abstract

AIM: To evaluate the relationship between measures of body adiposity and visceral adiposity index (VAI) and risk of metabolic syndrome (MS) and to identify the optimal cut-off points of each measurement in Thai polycystic ovary syndrome (PCOS).
METHODS: A cross-sectional study was completed physical examination, fasting plasma glucose, lipid profiles of 399 PCOS and 42 age-matched normal controls. Body mass index (BMI), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR) and VAI were calculated. Associations between different measures and MS were evaluated and the receiver-operating characteristic (ROC) curve was performed to determine appropriate cut-off points for identifying MS.
RESULTS: Percentage of MS in PCOS was 24.6%, whereas none MS in controls. Previously recommended cut-off values for body adiposity and VAI were significantly associated with MS. ROC curve analysis of the only PCOS showed newly obtained optimal cut-off points for BMI and VAI of ≥28 kg/m(2) (AUC = 0.90) and >5.6 (AUC = 0.94), respectively. Values found to be more accurate than the original ones. VAI was the best predictor, followed by BMI and WHtR.
CONCLUSION: All body adiposity and VAI parameters can predict the risk of MS. Optimal values for Thai PCOS were ≥28 kg/m(2) for BMI, ≥0.85 for WHR, ≥0.5 for WHtR and >5.6 for VAI.

Entities:  

Keywords:  Body adiposity; Thai; metabolic syndrome; polycystic ovary syndrome; visceral adiposity index

Mesh:

Year:  2015        PMID: 26503544     DOI: 10.3109/09513590.2015.1112785

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  11 in total

1.  Genetic association study from North India to analyze association of CYP19A1 and CYP17A1 with polycystic ovary syndrome.

Authors:  Ratneev Kaur; Tajinder Kaur; Anupam Kaur
Journal:  J Assist Reprod Genet       Date:  2018-03-22       Impact factor: 3.412

2.  Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.

Authors:  U Durmus; C Duran; S Ecirli
Journal:  J Endocrinol Invest       Date:  2016-11-12       Impact factor: 4.256

3.  Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome.

Authors:  Qianqian Yin; Jianhua Zheng; Yijuan Cao; Xiaonan Yan; Hong Zhang
Journal:  Int J Endocrinol       Date:  2021-08-17       Impact factor: 3.257

4.  Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women.

Authors:  Roshan Dadachanji; Anushree Patil; Beena Joshi; Srabani Mukherjee
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

5.  Visceral adiposity index is associated with lung function impairment: a population-based study.

Authors:  Sunyue He; Jie Yang; Xiaoyong Li; Hongxia Gu; Qing Su; Li Qin
Journal:  Respir Res       Date:  2021-01-06

6.  Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome.

Authors:  Małgorzata Kałużna; Magdalena Czlapka-Matyasik; Pola Kompf; Jerzy Moczko; Katarzyna Wachowiak-Ochmańska; Adam Janicki; Karolina Samarzewska; Marek Ruchała; Katarzyna Ziemnicka
Journal:  Ther Adv Endocrinol Metab       Date:  2022-01-10       Impact factor: 3.565

Review 7.  The Accuracy of Visceral Adiposity Index for the Screening of Metabolic Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Moniba Bijari; Sara Jangjoo; Nima Emami; Sara Raji; Mahdi Mottaghi; Roya Moallem; Ali Jangjoo; Amin Saberi
Journal:  Int J Endocrinol       Date:  2021-07-26       Impact factor: 3.257

8.  Percentage of Body Fat and Fat Mass Index as a Screening Tool for Metabolic Syndrome Prediction in Colombian University Students.

Authors:  Robinson Ramírez-Vélez; Jorge Enrique Correa-Bautista; Alejandra Sanders-Tordecilla; Mónica Liliana Ojeda-Pardo; Elisa Andrea Cobo-Mejía; Rocío Del Pilar Castellanos-Vega; Antonio García-Hermoso; Emilio González-Jiménez; Jacqueline Schmidt-RioValle; Katherine González-Ruíz
Journal:  Nutrients       Date:  2017-09-13       Impact factor: 5.717

9.  Three novel obese indicators perform better in monitoring management of metabolic syndrome in type 2 diabetes.

Authors:  Chun-Ming Ma; Na Lu; Rui Wang; Xiao-Li Liu; Qiang Lu; Fu-Zai Yin
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

10.  Performance of Two Novel Obesity Indicators for the Management of Metabolic Syndrome in Young Adults.

Authors:  Xiaoli Liu; Chunpeng Ma; Fuzai Yin; Rui Wang; Qiang Lu; Na Lu; Chunming Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-26       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.